Antonino Messina

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Traumatic Brain Injury

Bipolar Disorder

Inflammatory Response

Lipopolysaccharide Induced

Top Venues

Annals of general psychiatry

Anatomical science international

This page only lists publications with an associated author ORCID identifier.

Publications

Antonino Messina, Caterina Crescimanno, Giuseppe Cuccì, Filippo Caraci, Maria Salvina Signorelli
Cell adhesion molecules in the pathogenesis of the schizophrenia. Folia medica 65 (5) (2024)
Antonino Messina, Fabrizio Bella, Giuliana Maccarone, Alessandro Rodolico, Maria Salvina Signorelli
Neutrophil-Lymphocyte Ratio Values in Schizophrenia: A Comparison between Oral and Long-Acting Antipsychotic Therapies. Brain sciences 14 (6) (2024)
Antonino Messina, Fabrizio Bella, Giuliana Maccarone, Alessandro Rodolico, Maria Salvina Signorelli
Neutrophil-Lymphocyte Ratio Values in Schizophrenia: A Comparison between Oral and Long-Acting Antipsychotic Therapies. Brain sciences 14 (6) (2024)
Antonino Messina, Giuseppe Cuccì, Caterina Crescimanno, Maria Salvina Signorelli
Clinical anatomy of the precuneus and pathogenesis of the schizophrenia. Anatomical science international (2023)
Antonino Messina, Concerto Carmen, Alessandro Rodolico, Antonino Petralia, Filippo Caraci, Maria Salvina Signorelli
Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs-A Review. Brain sciences 13 (6) (2023)
Antonino Messina, Filippo Caraci, Eugenio Aguglia, Maria Salvina Signorelli
Catatonia-like behavior and immune activation: a crosstalk between psychopathology and pathology in schizophrenia. Annals of general psychiatry 22 (1) (2023)
Antonino Messina, Concerto Carmen, Alessandro Rodolico, Antonino Petralia, Filippo Caraci, Maria Salvina Signorelli
Is It Time for a Paradigm Shift in the Treatment of Schizophrenia? The Use of Inflammation-Reducing and Neuroprotective Drugs-A Review. Brain sciences 13 (6) (2023)